Treatment with recombinant human ISG15 induced NF-κB and STAT3 activation, tumor-cell EMT, and promoted tumor-cell migration and invasion in vitro (Fig. 7K, L and Fig. S6J-L). The gene discussed is NFKB1; the disease is neoplasm.